Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:33 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Use of Tranexamic Acid in Facial Fillers
NCT04373603 · University of Wisconsin, Madison · PHASE4 · withdrawn · last registry update 2022-07-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study closed prior to opening to enrollment, due to funding availability for study” | – | Registry record, University of Wisconsin, Madison |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PLG within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-06-22Results posted on the registry: Emory University, Baby aspirin + Tylenol/Acetaminophen (NCT04766996)
- 2023-06-22Also stopped (terminated): Emory University, Baby aspirin + Tylenol/Acetaminophen (NCT04766996)
- 2023-06-12Phase 3 first posted: University of Aarhus, Tranexamic acid + Saline (NCT05899465)
- 2023-06-01Results posted on the registry: Hospital for Special Surgery, New York, Tranexamic Acid (NCT04089865)
- 2023-05-16Also stopped (withdrawn): Wayne State University, Tranexamic Acid + Vehicle (NCT03361345)
- 2023-05-11Phase 3 first posted: Instituto Mexicano del Seguro Social, Tranexamic acid (NCT05855590)
- 2023-05-09Results posted on the registry: Gregory Yanik, Defibrotide (NCT04530604)
- 2023-04-25Results posted on the registry: The Reading Hospital and Medical Center, Tranexamic acid + Saline (NCT04902950)
- 2023-04-25Also stopped (terminated): The Reading Hospital and Medical Center, Tranexamic acid + Saline (NCT04902950)
- 2023-04-19Also stopped (terminated): Sheba Medical Center, tranexamic acid + Placebo (NCT03085394)
- 2023-04-18Phase 3 first posted: Instituto do Cancer do Estado de São Paulo, Tranexamic acid (NCT05816668)
- 2023-04-13Phase 3 first posted: Guangzhou Medical University, Tranexamic acid (NCT05811676)
- 2023-04-10Results posted on the registry: Montefiore Medical Center, Tranexamic acid (NCT04947514)
- 2023-04-07Results posted on the registry: Northwestern University, Tranexamic acid (NCT05082142)
- 2023-04-05Results posted on the registry: Stanford University, Tranexamic Acid 1,000 Mg/10 mL (100 Mg/mL) INTRAVEN VIAL (ML) (NCT04754230)
- 2023-03-30Results posted on the registry: Mayo Clinic, Tranexamic Acid (TXA) + Placebo (NCT03182751)
- 2023-03-20Results posted on the registry: University of Zimbabwe, Tranexamic acid injection (NCT04733157)
- 2023-02-06Phase 3 first posted: Unity Health Toronto, Tranexamic acid (TXA) + Placebo (NCT05713630)
- 2023-02-02Also stopped (withdrawn): Northwestern University, Tranexamic acid + Placebo (NCT05710146)
- 2023-02-02Phase 3 first posted: Northwestern University, Tranexamic acid + Placebo (NCT05710146)
- 2023-01-19Results posted on the registry: The George Washington University Biostatistics Center, Tranexamic Acid + Placebo (NCT03364491)
- 2023-01-18Also stopped (withdrawn): University of Wisconsin, Madison, Tranexamic Acid Irrigation (NCT04372940)
- 2022-11-25Results posted on the registry: Hospital for Special Surgery, New York, Tranexamic Acid + Placebo (NCT02253810)
- 2022-11-23Results posted on the registry: Hospital for Special Surgery, New York, E-Aminocaproic acid (NCT02257580)
- 2022-10-03Phase 3 first posted: London School of Hygiene and Tropical Medicine, Tranexamic acid (NCT05562609)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision